The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of FedEx Corporation (NYSE:FDX) shares was initiated concerning possible breaches of fiduciary duties by causing or allowing FedEx to engage in allegedly improper conducted related to the shipment of illegal pharmaceuticals..
Investors who purchased shares of FedEx Corporation (NYSE:FDX) and currently hold any of those NYSE:FDX shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain FedEx Corporation (NYSE:FDX officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
On July 10, 2014, FedEx Corporation was indicted by a federal grand jury in San Francisco in a 15-count indictment which included alleged drug trafficking and the alleged conspiracy to distribute controlled substances. FedEx Corporation’s alleged misconduct occurred despite the fact that United States drug enforcement officials had repeatedly warned FedEx Corporation to cease the illicit transportation of pharmaceutical drugs.
Those who purchased shares of FedEx Corporation (NYSE:FDX), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego